Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12601
PUT
Neuronetics
STIM
$165M
| $22.3K | ﹤0.01% |
15,400
-64,100
| -81% | -$102K |
2024 Q4
5 quarters
|
|
12602
PUT
Ring Energy
REI
$341M
| $22.2K | ﹤0.01% |
14,500
-86,500
| -86% | -$110K |
2020 Q4
21 quarters
|
|
|
SDM
12603
DELISTED
Smart Digital Group
SDM
| $22.1K | ﹤0.01% |
15,939
| – | – |
2025 Q3
2 quarters
|
|
12604
Fractyl Health
GUTS
$64.7M
| $22.1K | ﹤0.01% |
48,196
-180,789
| -79% | -$167K |
2025 Q3
2 quarters
|
|
|
BGMS
12605
Bio Green Med Solution Inc
BGMS
$5.83M
| $22.1K | ﹤0.01% |
+22,051
| New | +$24.4K |
2026 Q1
0 quarters
|
|
12606
PUT
Beam Global
BEEM
$25.6M
| $22.1K | ﹤0.01% |
+15,000
| New | +$23.6K |
2026 Q1
0 quarters
|
|
12607
CALL
RLX Technology
RLX
$2.09B
| $22K | ﹤0.01% |
10,000
-21,700
| -68% | -$49.9K |
2021 Q1
20 quarters
|
|
12608
HeartSciences Inc Warrant
HSCSW
| $22K | ﹤0.01% |
192,587
-2,972
| -2% | -$281 |
2022 Q4
13 quarters
|
|
|
LGPS
12609
LogProstyle Inc
LGPS
$17.7M
| $21.7K | ﹤0.01% |
32,154
-20,652
| -39% | -$17.1K |
2025 Q3
2 quarters
|
|
12610
SelectQuote
SLQT
$73.7M
| $21.6K | ﹤0.01% |
34,302
-257,120
| -88% | -$270K |
2025 Q3
2 quarters
|
|
12611
CALL
Douglas Elliman
DOUG
$141M
| $21.5K | ﹤0.01% |
13,100
+1,500
| +13% | +$3.48K |
2025 Q4
1 quarter
|
|
|
CHAI
12612
Core AI Holdings Inc
CHAI
$7.38M
| $21.3K | ﹤0.01% |
21,132
-25,435
| -55% | -$44.2K |
2025 Q4
1 quarter
|
|
|
CIF
12613
DELISTED
MFS Intermediate High Income Fund
CIF
| $21.1K | ﹤0.01% |
13,043
-953
| -7% | -$1.61K |
2025 Q4
1 quarter
|
|
12614
CALL
HF Foods Group
HFFG
$90.6M
| $21.1K | ﹤0.01% |
+11,400
| New | +$21.8K |
2026 Q1
0 quarters
|
|
12615
Local Bounti
LOCL
$25.5M
| $20.9K | ﹤0.01% |
+18,011
| New | +$30.6K |
2026 Q1
0 quarters
|
|
12616
PUT
BRC Inc
BRCC
$129M
| $20.6K | ﹤0.01% |
+2,660
| New | +$22.4K |
2026 Q1
0 quarters
|
|
12617
PUT
LiveWire
LVWR
$322M
| $20.6K | ﹤0.01% |
12,400
-13,800
| -53% | -$30.7K |
2024 Q4
5 quarters
|
|
12618
Borealis Foods
BRLS
$26M
| $20.5K | ﹤0.01% |
+14,446
| New | +$20.6K |
2026 Q1
0 quarters
|
|
12619
Greenlane Holdings
GNLN
$1.85M
| $20.4K | ﹤0.01% |
+6,903
| New | +$57.2K |
2026 Q1
0 quarters
|
|
12620
PUT
VistaGen Therapeutics
VTGN
$12.5M
| $20.4K | ﹤0.01% |
35,700
-429,400
| -92% | -$261K |
2023 Q3
10 quarters
|
|
12621
BTCS Inc
BTCS
$75M
| $20.4K | ﹤0.01% |
+14,677
| New | +$30K |
2026 Q1
0 quarters
|
|
12622
PUT
Valens Semiconductor
VLN
$207M
| $20.3K | ﹤0.01% |
18,000
+4,600
| +34% | +$7.22K |
2024 Q4
5 quarters
|
|
12623
CALL
Standard BioTools
LAB
$292M
| $20.2K | ﹤0.01% |
22,000
+3,500
| +19% | +$4.24K |
2020 Q2
23 quarters
|
|
|
PRHI
12624
Presurance Holdings
PRHI
$25.7M
| $20.1K | ﹤0.01% |
5,635
-1,578
| -22% | -$7.56K |
2025 Q4
1 quarter
|
|
12625
PUT
Ocean Power Technologies
OPTT
$9.18M
| $20.1K | ﹤0.01% |
1,913
+33
| +2% | +$426 |
2024 Q3
6 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.